Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 1/7/2026

Colorectal Cancer Screening Discontinuation Recommendations for Older Adults

Age ≤ 75 years

Age 76 – 85 years

Age ≥ 86 years

Individuals With Prior Negative Screening (up‑to‑date)

Individuals Without Prior Screening

Life‑Expectancy Considerations

Guideline Authority & General Principles

Colorectal Cancer Screening Age Guidelines

Age to Stop Screening: Evidence-Based Recommendations

  • Individuals who are up to date with screening and have negative prior screening tests, particularly high-quality colonoscopy, should consider stopping screening at age 75 years or when life expectancy is less than 10 years 4, 5, 6
  • For persons aged 76-85 years, the decision to continue screening should be individualized based on overall health status 6, life expectancy 4, and patient preferences 5, 7
  • Individuals over age 85 years should be discouraged from continuing colorectal cancer screening 6, 8

Specific Considerations for Different Patient Groups

  • Persons without prior screening may benefit from screening up to age 85, depending on their age and comorbidities 4, 9
  • Individuals with severe comorbidities should stop screening at age 66 or younger, regardless of sex 9

Screening Modality Considerations

  • Colonoscopy carries higher procedural risks in older adults 5
  • FIT testing may be more appropriate for older adults with comorbidities 9

Balancing Benefits and Harms in Older Adults

  • The benefits of continued screening decrease with age while potential harms increase 7
  • Potential harms include procedural complications 4, false-positive results leading to unnecessary follow-up procedures 4, and overdiagnosis of cancer that would not have caused symptoms in the patient's lifetime 7

Common Pitfalls to Avoid

  • Continuing screening beyond age 85 when evidence shows harms outweigh benefits 8
  • Stopping screening too early in healthy individuals with no prior screening history 9
  • Not accounting for patient preferences in the decision-making process 4